Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

1.8K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.8K
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

1.0K
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.0K
Amyloid Fibrils03:03

Amyloid Fibrils

12.1K
Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining,...
12.1K
Human Genetics01:28

Human Genetics

1.7K
Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
1.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same authorSame journal

Editorial overview for neurobiology of disease 2026.

Current opinion in neurobiology·2026
Same author

Novel Monoclonal Antibody Detects Small Aβ Oligomers More Sensitively Than Lecanemab in Alzheimer's Disease CSF, Serum and Culture Media.

Annals of neurology·2026
Same author

<i>ROBO2</i> Variants Associated With Atrial Septal Defect Define a Novel Regulatory Element.

Circulation. Genomic and precision medicine·2026
Same author

Developing Topics.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2025
Same author

INPP5D/SHIP1 is a dual regulator of endo-lysosome function and selective phagocytosis in human microglia.

bioRxiv : the preprint server for biology·2025
Same author

Plasma TDP-43 is a potential biomarker for advanced limbic-predominant age-related TDP-43 encephalopathy neuropathologic change.

Molecular neurodegeneration·2025

Related Experiment Video

Updated: Feb 20, 2026

Mapping Alzheimer's Disease Variants to Their Target Genes Using Computational Analysis of Chromatin Configuration
04:41

Mapping Alzheimer's Disease Variants to Their Target Genes Using Computational Analysis of Chromatin Configuration

Published on: January 9, 2020

19.5K

Decoding Alzheimer's genetic risk through intercellular communication in the human brain: Lessons from Clusterin.

Alexandra M Lish1, Tracy L Young-Pearse1

  • 1Ann Romney Center for Neurologic Diseases, Department of Neurology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.

Current Opinion in Neurobiology
|February 18, 2026
PubMed
Summary

Common genetic variants in Alzheimer's disease (AD) disrupt glial-neuronal communication. This review explores how human brain data and cellular models reveal the impact of these genetic risk factors on intercellular pathways, guiding new therapeutic strategies.

More Related Videos

Generalized Psychophysiological Interaction PPI Analysis of Memory Related Connectivity in Individuals at Genetic Risk for Alzheimer's Disease
09:38

Generalized Psychophysiological Interaction PPI Analysis of Memory Related Connectivity in Individuals at Genetic Risk for Alzheimer's Disease

Published on: November 14, 2017

15.8K
Quantitative 3D In Silico Modeling q3DISM of Cerebral Amyloid-beta Phagocytosis in Rodent Models of Alzheimer's Disease
09:33

Quantitative 3D In Silico Modeling q3DISM of Cerebral Amyloid-beta Phagocytosis in Rodent Models of Alzheimer's Disease

Published on: December 26, 2016

8.5K

Related Experiment Videos

Last Updated: Feb 20, 2026

Mapping Alzheimer's Disease Variants to Their Target Genes Using Computational Analysis of Chromatin Configuration
04:41

Mapping Alzheimer's Disease Variants to Their Target Genes Using Computational Analysis of Chromatin Configuration

Published on: January 9, 2020

19.5K
Generalized Psychophysiological Interaction PPI Analysis of Memory Related Connectivity in Individuals at Genetic Risk for Alzheimer's Disease
09:38

Generalized Psychophysiological Interaction PPI Analysis of Memory Related Connectivity in Individuals at Genetic Risk for Alzheimer's Disease

Published on: November 14, 2017

15.8K
Quantitative 3D In Silico Modeling q3DISM of Cerebral Amyloid-beta Phagocytosis in Rodent Models of Alzheimer's Disease
09:33

Quantitative 3D In Silico Modeling q3DISM of Cerebral Amyloid-beta Phagocytosis in Rodent Models of Alzheimer's Disease

Published on: December 26, 2016

8.5K

Area of Science:

  • Neuroscience
  • Genetics
  • Cell Biology

Background:

  • Late-onset Alzheimer's disease (AD) genetics involve common, low-penetrance variants, often in noncoding regions and enriched in glial cells.
  • These variants complicate linking genetic risk to cellular function, unlike rare early-onset AD mutations.
  • Growing evidence implicates glial-enriched risk genes in disrupting essential glial-neuronal communication, impacting synaptic health and immune responses.

Purpose of the Study:

  • To review recent progress in understanding the cellular impact of AD risk variants by focusing on glial-neuronal communication.
  • To illustrate how human brain studies map cell-type-specific gene expression and intercellular networks related to genetic risk.
  • To discuss the use of human stem cell-derived models for testing hypotheses on AD genetic risk.

Main Methods:

  • Integration of large-scale postmortem human brain datasets.
  • Utilizing human stem cell-derived co-culture and 3D models for experimental testing.
  • Case study analysis of the CLU (Clusterin) risk locus.

Main Results:

  • Human brain studies have mapped cell-type-specific gene expression and intercellular networks associated with AD genetic risk.
  • Human stem cell models are being employed to experimentally validate the functional consequences of AD risk variants.
  • The CLU gene exemplifies how risk variants modulate glial inflammation, lipid exchange, and neuronal vulnerability.

Conclusions:

  • Decoding the cellular impact of AD polygenic variation requires integrative strategies combining human brain data and cellular models.
  • Understanding glial-neuronal communication pathways is crucial for deciphering AD genetic risk.
  • This framework facilitates linking genotype to function and identifies new therapeutic targets in intercellular biology.